Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NTRA Natera, Inc. daily Stock Chart
NTRA [NASD]
Natera, Inc.
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E- EPS (ttm)-1.86 Insider Own2.00% Shs Outstand76.16M Perf Week3.83%
Market Cap2.89B Forward P/E- EPS next Y-1.91 Insider Trans-21.50% Shs Float73.88M Perf Month2.05%
Income-121.50M PEG- EPS next Q-0.55 Inst Own89.20% Short Float4.88% Perf Quarter-4.07%
Sales286.10M P/S10.09 EPS this Y14.20% Inst Trans2.87% Short Ratio5.25 Perf Half Y28.20%
Book/sh1.20 P/B31.59 EPS next Y-1.60% ROA-37.60% Target Price42.50 Perf Year134.45%
Cash/sh3.13 P/C12.12 EPS next 5Y- ROE-226.10% 52W Range14.71 - 40.92 Perf YTD12.53%
Dividend- P/FCF- EPS past 5Y-21.70% ROI-73.80% 52W High-7.36% Beta1.28
Dividend %- Quick Ratio2.30 Sales past 5Y36.10% Gross Margin39.20% 52W Low157.72% ATR1.33
Employees975 Current Ratio2.30 Sales Q/Q19.30% Oper. Margin-38.90% RSI (14)58.77 Volatility3.68% 3.70%
OptionableYes Debt/Eq1.46 EPS Q/Q32.80% Profit Margin-42.50% Rel Volume0.57 Prev Close37.13
ShortableYes LT Debt/Eq0.87 EarningsMar 10 AMC Payout- Avg Volume687.21K Price37.91
Recom1.80 SMA205.09% SMA506.65% SMA20019.63% Volume395,753 Change2.10%
Oct-05-18Initiated JP Morgan Neutral $26
Jul-05-18Reiterated Piper Jaffray Overweight $18 → $21
Aug-07-17Reiterated Morgan Stanley Overweight $18 → $13
Nov-10-16Reiterated The Benchmark Company Buy $16 → $20
May-23-16Reiterated The Benchmark Company Buy $15 → $16
May-11-16Reiterated The Benchmark Company Buy $14 → $15
Apr-19-16Initiated The Benchmark Company Buy $14
Sep-28-15Upgrade Wedbush Neutral → Outperform
Aug-14-15Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-04-15Initiated Robert W. Baird Outperform $20
Jul-27-15Initiated Wedbush Neutral $20
Jul-27-15Initiated Piper Jaffray Overweight $24
Jul-27-15Initiated Morgan Stanley Equal-Weight $20
Feb-19-20 08:57PM  Natera Announces Fourth Quarter and Fiscal 2019 Earnings Conference Call PR Newswire
Feb-18-20 09:20AM  Natera Files False Advertising Counterclaim Against CareDx PR Newswire
Feb-11-20 09:05AM  Elicio Therapeutics and Natera to Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002 PR Newswire
09:05AM  Elicio Therapeutics and Natera To Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002 Business Wire
Jan-27-20 09:13AM  Natera Files Suit Against ArcherDX for Patent Infringement PR Newswire
Jan-15-20 08:42AM  National Cancer Center Japan Launches Multi-Center Randomized Trial Using Signatera MRD Testing in Stage II-III Colorectal Cancer PR Newswire
Jan-14-20 12:35AM  Edited Transcript of NTRA earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Jan-13-20 09:26AM  Natera Announces New Early Priority Date cfDNA Patent, Files Suit Against CareDx PR Newswire
Jan-09-20 09:05AM  Natera Launches BESPOKE CRC Study to Evaluate Outcomes in 1,000 Signatera Patients with Stage II-III Colorectal Cancer PR Newswire
Jan-08-20 07:35AM  Natera To Webcast Live Presentation at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-06-20 08:30AM  Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents PR Newswire
Dec-19-19 11:32AM  Natera Receives Final Medicare Coverage for Prospera Organ Transplant Rejection Assessment Test PR Newswire +5.66%
Dec-07-19 05:36PM  Hedge Funds Have Never Been This Bullish On Natera Inc (NTRA) Insider Monkey
Nov-27-19 08:20AM  Panorama Publication Demonstrates Utility of Measuring Individual Fetal Fractions in Twin Pregnancies PR Newswire
Nov-15-19 07:21AM  What Kind Of Share Price Volatility Should You Expect For Natera, Inc. (NASDAQ:NTRA)? Simply Wall St.
Nov-06-19 06:25PM  Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM  Natera Reports Third Quarter 2019 Financial Results PR Newswire
Oct-30-19 07:03AM  Natera Announces Third Quarter 2019 Earnings Conference Call PR Newswire
Oct-25-19 10:11AM  Hedge Funds Are Betting On Natera Inc (NTRA) Insider Monkey
Oct-16-19 10:00PM  Natera Announces Pricing of Follow-On Offering PR Newswire -7.45%
Oct-15-19 06:10PM  Natera stock falls after hours on secondary-offering announcement MarketWatch
05:46PM  Natera Launches Proposed Follow-On Offering PR Newswire
Oct-03-19 08:45AM  Natera to Host Investor Conference Call to Discuss Progress in its Oncology Business PR Newswire
Sep-26-19 09:47AM  Natera (NTRA) Scales 52-Week High: What's Driving the Stock? Zacks
Sep-25-19 09:03AM  Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring PR Newswire
Sep-13-19 11:45AM  CBR® Acquires Evercord Newborn Stem Cell Business from Natera PR Newswire
11:45AM  CBR to Acquire Natera's Evercord Cord Blood Business PR Newswire
Sep-09-19 11:01AM  Natera Publishes Largest NIPT Outcomes Study Demonstrating Robust Clinical Performance Over a 4-year Period PR Newswire -7.55%
Sep-05-19 10:06AM  Did Natera, Inc. (NASDAQ:NTRA) Insiders Sell Shares? Simply Wall St.
Sep-04-19 09:03AM  Natera to Present at the Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire
Aug-29-19 09:16AM  Natera Appoints Rowan Chapman to its Board of Directors PR Newswire
Aug-28-19 09:43AM  Natera to Webcast Live Presentation at the Baird 2019 Global Healthcare Conference PR Newswire
Aug-22-19 01:13PM  Medicare Issues Positive Draft Local Coverage Determination for Natera's Signatera MRD Test in Colorectal Cancer PR Newswire
09:16AM  Panorama NIPT Achieves 2 Million Test Milestone PR Newswire
Aug-14-19 06:37AM  Edited Transcript of NTRA earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -7.68%
Aug-12-19 09:15PM  Natera Inc (NTRA) CEO Steven Leonard Chapman Sold $3.3 million of Shares GuruFocus.com -9.48%
Aug-07-19 05:35PM  Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:07PM  Natera Reports Second Quarter 2019 Financial Results PR Newswire
Aug-05-19 08:02AM  Publication Demonstrates Unique Ability of Panorama Test to Determine Zygosity in Twin Pregnancies PR Newswire -6.28%
Jul-31-19 08:51PM  Natera Announces Second Quarter 2019 Earnings Conference Call PR Newswire
Jul-22-19 02:38PM  Is Natera's (NASDAQ:NTRA) Share Price Gain Of 104% Well Earned? Simply Wall St.
Jul-12-19 05:26PM  Here's Why Natera Stock Soared 97.6% in the First Half of 2019 Motley Fool
Jun-24-19 08:07AM  New ProActive Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients PR Newswire
Jun-19-19 06:41PM  46 and You: Genetic Testing = Giant Growth Market Zacks
06:00PM  Did Hedge Funds Drop The Ball On Natera Inc (NTRA) ? Insider Monkey
07:27AM  Natera, Inc.'s Shares March Higher, Can It Continue? Zacks
Jun-13-19 07:57PM  Edited Transcript of NTRA earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-06-19 06:59AM  What Kind Of Shareholder Owns Most Natera, Inc. (NASDAQ:NTRA) Stock? Simply Wall St.
Jun-03-19 08:34AM  Data Presented at ASCO Shows Natera's Signatera Test Detects Immunotherapy Treatment Response in Metastatic Cancers PR Newswire
May-22-19 09:27AM  Natera, Inc. (NTRA) Shares March Higher, Can It Continue? Zacks
May-21-19 09:40AM  Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera Kidney Transplant Test PR Newswire
May-20-19 10:20AM  OncoCyte (OCX) Catches Eye: Stock Jumps 7.3% Zacks
May-10-19 02:24PM  Natera (NTRA) Q1 2019 Earnings Call Transcript Motley Fool +22.25%
May-09-19 07:55PM  Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:49PM  Natera: 1Q Earnings Snapshot Associated Press
04:12PM  Natera Reports First Quarter 2019 Financial Results PR Newswire
12:04PM  New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier PR Newswire
May-07-19 08:27AM  Signatera Blood Test Detects Bladder Cancer Relapse Up to Eight Months Earlier Than Current Clinical Standards PR Newswire
May-06-19 11:55AM  FDA Grants Breakthrough Device Designation to Natera's Signatera Test PR Newswire
May-03-19 08:24PM  Did Hedge Funds Drop The Ball On Natera Inc (NTRA)? Insider Monkey
May-02-19 08:50PM  Natera Announces First Quarter 2019 Earnings Conference Call PR Newswire
Apr-17-19 11:43PM  Natera Announces Pricing of Follow-On Offering PR Newswire -6.40%
07:48AM  The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 04:12PM  Natera Launches Proposed Follow-On Offering PR Newswire
10:13AM  New Publication Validates Clinical Performance of Signatera for Recurrence Monitoring and MRD Assessment in Breast Cancer PR Newswire
Apr-15-19 01:20PM  How Does Natera, Inc. (NASDAQ:NTRA) Affect Your Portfolio Volatility? Simply Wall St.
Apr-10-19 08:03AM  Natera Announces Plans to Commercialize Tumor Whole Exome Sequencing from Plasma PR Newswire
Mar-28-19 12:46PM  Medicare Issues Draft Local Coverage Determination for Natera's New Prospera Kidney Transplant Rejection Test PR Newswire +9.74%
07:15AM  Analysis: Positioning to Benefit within JD, Five9, Ambarella, Natera, Methanex, and Virtusa Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Mar-26-19 08:04AM  Natera to Partner with AMAL Therapeutics on Clinical Trial Using Signatera MRD Test to Assess Treatment Response to Colorectal Cancer Vaccine PR Newswire
Mar-21-19 01:59AM  Edited Transcript of NTRA earnings conference call or presentation 12-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-13-19 01:45PM  Here's Why Natera Rose as Much as 24.7% Today Motley Fool +19.09%
Mar-12-19 08:31PM  Natera Inc (NTRA) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:35PM  After-Hours News: Kraft Heinz and Natera Are Rising Motley Fool
06:05PM  Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates Zacks
05:03PM  Natera: 4Q Earnings Snapshot Associated Press
04:05PM  Natera Reports Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire
02:30PM  Natera, Inc. to Host Earnings Call ACCESSWIRE
Mar-11-19 06:03AM  Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq Technology Platform PR Newswire +6.55%
Mar-06-19 04:53PM  /C O R R E C T I O N -- Natera, Inc./ PR Newswire
Mar-05-19 02:17PM  Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call PR Newswire
Feb-27-19 11:11AM  When Will Natera, Inc. (NASDAQ:NTRA) Breakeven? Simply Wall St.
Feb-22-19 09:00AM  Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay PR Newswire
Feb-19-19 01:46PM  Natera Presents Outcomes Data at SMFM Annual Meeting Showing Strong Clinical Performance of Its SNP-Based Non-Invasive Prenatal Test PR Newswire
Feb-01-19 07:30AM  Natera Announces Agreement with One Lambda to Co-Distribute Its Kidney Transplant Rejection Test PR Newswire +5.59%
Jan-22-19 07:30AM  Consolidated Research: 2019 Summary Expectations for Marathon Petroleum, AMC Entertainment, JetBlue Airways, Acceleron Pharma, Natera, and AquaVenture Fundamental Analysis, Key Performance Indications GlobeNewswire
Jan-07-19 08:03AM  Natera Announces Publication of Kidney Transplant Validation Study, Demonstrating Superior Data in Detection of Clinical and Subclinical Rejection PR Newswire
Jan-04-19 02:02PM  Natera To Webcast Live Presentation at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire
08:03AM  Natera Obtains Z-Codes for Signatera MRD and Treatment Monitoring Test in Oncology PR Newswire
Jan-02-19 04:02PM  Natera Appoints Steve Chapman CEO and Robert Schueren COO; Matthew Rabinowitz Moves to Executive Chairman PR Newswire -7.23%
Dec-25-18 10:14AM  Who Has Been Selling Natera, Inc. (NASDAQ:NTRA) Shares? Simply Wall St.
Dec-14-18 10:11PM  Is Natera Inc (NTRA) Going to Burn These Hedge Funds? Insider Monkey -7.27%
Dec-06-18 08:03AM  Natera Presents Breast Cancer Data at SABCS Showing Ability of Signatera (RUO) to Detect Molecular Residual Disease Up to Two Years Prior to Clinical Relapse and Predict Treatment Response PR Newswire
Nov-29-18 08:04AM  Natera Achieves Enrollment Goal of 20,000 Patients in SMART Study PR Newswire
Nov-28-18 08:25AM  New Research: Key Drivers of Growth for Mersana Therapeutics, Maiden, Payment Data, CareDx, Natera, and Spero Therapeutics Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire +9.94%
08:03AM  Natera Receives Unique Z-Code for Its Kidney Transplant Rejection Monitoring Test PR Newswire
Nov-27-18 08:06AM  PerkinElmer's Vanadis NIPT CE Mark Boosts Prenatal Prospects Zacks
Nov-14-18 07:42AM  Edited Transcript of NTRA earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-09-18 01:01PM  Earnings Results Make 3 Stocks Move Friday GuruFocus.com -18.57%
Nov-08-18 06:15PM  Natera (NTRA) Reports Q3 Loss, Misses Revenue Estimates Zacks
Natera, Inc. provides preconception and prenatal genetic testing services. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora products of conception test to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Evercord, a cord blood and cord tissue processing and storage service; and Signatera, a circulating tumor DNA technology that analyzes and tracks mutations to an individual's tumor. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners in the United States and internationally. Natera, Inc. has research collaborations with the Institut Jules Bordet and Fox Chase Cancer Center; and a partnership agreement with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays for use by biopharmaceutical and clinical customers. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brophy Michael BurkesChief Financial OfficerFeb 03Option Exercise10.182,25122,92020,752Feb 04 05:26 PM
Brophy Michael BurkesChief Financial OfficerFeb 03Sale35.222,25179,28018,501Feb 04 05:26 PM
Chapman Steven LeonardChief Executive OfficerJan 16Option Exercise11.55116,6181,346,845139,340Jan 17 09:15 PM
Chapman Steven LeonardChief Executive OfficerJan 16Sale35.00139,3404,876,9000Jan 17 09:15 PM
Rabinowitz MatthewExecutive ChairmanJan 14Sale33.481274,2521,204,973Jan 15 04:21 PM
HEALY JAMESDirectorJan 10Option Exercise11.1122,338248,06329,616Jan 14 04:13 PM
Schueren Robert AlanChief Operating OfficerJan 08Sale34.998,167285,76320,225Jan 09 05:12 PM
Chapman Steven LeonardChief Executive OfficerJan 07Option Exercise9.591,84917,73224,571Jan 08 06:51 PM
Chapman Steven LeonardChief Executive OfficerJan 07Sale35.001,84964,71522,722Jan 08 06:51 PM
Chapman Steven LeonardChief Executive OfficerJan 03Sale32.014,739151,69022,722Jan 06 05:42 PM
Brophy Michael BurkesChief Financial OfficerJan 02Option Exercise9.596255,99419,126Jan 02 07:28 PM
Brophy Michael BurkesChief Financial OfficerJan 02Sale33.8662521,16318,501Jan 02 07:28 PM
Brophy Michael BurkesChief Financial OfficerDec 30Option Exercise10.232,86029,26021,361Jan 02 07:28 PM
Brophy Michael BurkesChief Financial OfficerDec 30Sale33.632,86096,18218,501Jan 02 07:28 PM
Chapman Steven LeonardChief Executive OfficerDec 23Sale36.9355820,60714,961Dec 23 06:49 PM
Sheena JonathanChief Technology OfficerDec 23Sale36.9350018,465243,403Dec 23 06:49 PM
Brophy Michael BurkesChief Financial OfficerDec 23Sale36.9344316,36018,501Dec 23 06:48 PM
Rabinowitz MatthewExecutive ChairmanDec 18Sale35.6016,856600,1031,204,793Dec 18 06:41 PM
Rabinowitz MatthewExecutive ChairmanDec 17Sale37.5033,3331,249,9141,221,649Dec 18 06:41 PM
Sheena JonathanChief Technology OfficerDec 16Option Exercise4.37100,000436,892305,305Dec 18 06:41 PM
Rabinowitz MatthewExecutive ChairmanDec 16Sale37.7333,3331,257,6581,254,982Dec 18 06:41 PM
Sheena JonathanChief Technology OfficerDec 16Sale37.69100,0003,769,416242,786Dec 18 06:41 PM
Chapman Steven LeonardChief Executive OfficerDec 10Sale36.131,14841,47814,402Dec 11 04:11 PM
Brophy Michael BurkesChief Financial OfficerDec 10Sale36.131,19943,32117,827Dec 11 04:11 PM
Rabinowitz MatthewExecutive ChairmanDec 10Sale36.131,40950,9081,288,315Dec 11 04:11 PM
Sheena JonathanChief Technology OfficerDec 10Sale36.131,02737,106242,786Dec 11 04:10 PM
Brophy Michael BurkesChief Financial OfficerNov 29Option Exercise10.232,85929,25018,864Dec 03 04:27 PM
Brophy Michael BurkesChief Financial OfficerNov 29Sale37.502,859107,21316,005Dec 03 04:27 PM
Brophy Michael BurkesChief Financial OfficerOct 30Option Exercise10.232,85929,25018,864Nov 01 04:14 PM
Brophy Michael BurkesChief Financial OfficerOct 30Sale38.252,859109,35716,005Nov 01 04:14 PM
Brophy Michael BurkesChief Financial OfficerOct 21Sale40.0015,701628,04016,005Oct 23 04:23 PM
Rabinowitz MatthewExecutive ChairmanOct 14Sale38.201485,6531,286,906Oct 15 04:22 PM
Brophy Michael BurkesChief Financial OfficerSep 30Option Exercise10.014,03240,37135,738Oct 02 05:28 PM
Brophy Michael BurkesChief Financial OfficerSep 30Sale32.014,032129,06431,706Oct 02 05:28 PM
Sheena JonathanChief Technology OfficerSep 23Sale33.5350016,765241,521Sep 24 05:02 PM
Brophy Michael BurkesChief Financial OfficerSep 23Sale33.5344414,88731,706Sep 24 05:01 PM
Chapman Steven LeonardChief Executive OfficerSep 23Sale33.5355918,74413,254Sep 24 05:02 PM
Chapman Steven LeonardChief Executive OfficerSep 20Sale33.199,424312,75712,696Sep 23 07:07 PM
Schueren Robert AlanChief Operating OfficerSep 20Sale33.1912,545416,33512,455Sep 23 07:07 PM
Brophy Michael BurkesChief Financial OfficerSep 20Sale33.199,972330,94431,033Sep 23 07:04 PM
Sheena JonathanChief Technology OfficerSep 10Sale29.501,03330,469240,904Sep 11 04:41 PM
Brophy Michael BurkesChief Financial OfficerSep 10Sale29.501,20635,57216,005Sep 11 04:41 PM
Chapman Steven LeonardChief Executive OfficerSep 10Sale29.501,15534,0683,370Sep 11 04:40 PM
Rabinowitz MatthewExecutive ChairmanSep 10Sale29.501,41741,7961,286,747Sep 11 04:40 PM
Brophy Michael BurkesChief Financial OfficerSep 04Option Exercise9.487873914,268Sep 06 04:56 PM
Brophy Michael BurkesChief Financial OfficerSep 04Sale32.49782,53414,190Sep 06 04:56 PM
Brophy Michael BurkesChief Financial OfficerAug 30Option Exercise10.083,48435,10617,674Sep 03 05:35 PM
Brophy Michael BurkesChief Financial OfficerAug 30Sale32.973,484114,86714,190Sep 03 05:35 PM
Chapman Steven LeonardChief Executive OfficerAug 09Option Exercise9.6991,373885,815101,225Aug 12 06:32 PM
Sheena JonathanChief Technology OfficerAug 09Option Exercise2.66125,000332,113364,645Aug 12 06:33 PM
Sheena JonathanChief Technology OfficerAug 09Sale32.59125,0004,074,227239,645Aug 12 06:33 PM
Chapman Steven LeonardChief Executive OfficerAug 09Sale33.0098,9963,266,8682,229Aug 12 06:32 PM
Sheena JonathanChief Technology OfficerAug 08Option Exercise2.66125,000332,113364,645Aug 12 06:33 PM
Brophy Michael BurkesChief Financial OfficerAug 08Option Exercise10.0243,954440,29958,144Aug 12 06:33 PM
Brophy Michael BurkesChief Financial OfficerAug 08Sale29.0043,9541,274,66614,190Aug 12 06:33 PM
Sheena JonathanChief Technology OfficerAug 08Sale30.14125,0003,767,547239,645Aug 12 06:33 PM
Rabinowitz MatthewExecutive ChairmanJul 15Sale25.841543,9791,285,346Jul 16 04:41 PM
Brophy Michael BurkesChief Financial OfficerJun 24Sale25.192756,92714,190Jun 25 04:46 PM
Chapman Steven LeonardChief Executive OfficerJun 24Sale25.193909,8249,852Jun 25 04:46 PM
Sheena JonathanChief Technology OfficerJun 24Sale25.1950012,595239,645Jun 25 04:46 PM
Rabinowitz MatthewExecutive ChairmanJun 10Sale24.791,41835,1541,285,194Jun 11 04:45 PM
Chapman Steven LeonardChief Executive OfficerJun 10Sale24.7979419,6849,125Jun 11 04:46 PM
Brophy Michael BurkesChief Financial OfficerJun 10Sale24.7974718,51913,348Jun 11 04:44 PM
Sheena JonathanChief Technology OfficerJun 10Sale24.791,03325,610239,028Jun 11 04:43 PM
Rabinowitz MatthewExecutive ChairmanApr 15Sale20.2561412,4341,283,794Apr 16 09:28 PM
Sheena JonathanChief Technology OfficerMar 29Option Exercise2.662,6206,961240,390Apr 02 04:51 PM
Sheena JonathanChief Technology OfficerMar 29Sale20.502,62053,710237,770Apr 02 04:51 PM
Sheena JonathanChief Technology OfficerMar 22Sale20.2050610,221237,770Mar 22 08:09 PM
Brophy Michael BurkesChief Financial OfficerMar 22Sale20.202735,51411,075Mar 25 08:10 PM
Chapman Steven LeonardChief Executive OfficerMar 22Sale20.203847,7577,623Mar 25 08:11 PM
Sheena JonathanChief Technology OfficerMar 21Option Exercise2.6671,317189,482308,475Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 21Sale20.5071,3171,462,006237,158Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 20Option Exercise2.66118,463314,744355,621Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 20Sale20.50118,4632,428,515237,158Mar 22 08:09 PM
Sheena JonathanChief Technology OfficerMar 13Option Exercise2.6657,600153,037294,758Mar 15 05:15 PM
Sheena JonathanChief Technology OfficerMar 13Sale20.5123,356478,997271,402Mar 15 05:15 PM
Chapman Steven LeonardChief Operating OfficerMar 11Sale16.003,41054,5726,889Mar 12 05:17 PM
Rabinowitz MatthewExecutive ChairmanMar 11Sale16.005,67290,7711,283,181Mar 12 05:16 PM
Sheena JonathanChief Technology OfficerMar 11Sale16.003,04348,698237,158Mar 12 05:14 PM
Brophy Michael BurkesChief Financial OfficerMar 11Sale16.003,19251,08310,230Mar 12 05:12 PM
open in yahoo | open in reuters | open in google